Asia Pacific Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others) 

Code: BMIRE00024995 | Pages: 167 | Industry: Pharmaceuticals | Date: Jun 2022 | Type: Regional

The generic injectables market in Asia Pacific is expected to grow from US$ 26,606.06 million in 2021 to US$ 55,751.62 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028.

The patents of branded injectables in several countries are likely to expire in the upcoming years, offering numerous remunerative opportunities to the generic injectables manufacturers. The shortage of branded medicines in India and the expiry of branded drug patents have prompted generic injectable manufacturers to introduce advanced drug delivery systems, including self-injection devices. Biological E Limited, an Indian biotechnology and biopharmaceutical company based in Hyderabad, Telangana, is gaining recognition for broadening its portfolio with the addition of 20 routine and injectable products. Thus, generic injectables companies are tapping regulated markets and exploring other markets to generate incomes and establish stable revenue streams. Additionally, manufacturers in the generic injectables market are becoming future-ready by maintaining adequate supply chains to prevent vulnerabilities, such as those caused by the COVID-19 outbreak. Zydus Cadila is significantly reducing the price of its generic version of Remdesivir, namely Remdac. Thus, the nearing expiry of patent validity of branded drugs is likely to provide significant opportunities to generic drug manufacturers, including the companies offering generic injectables.

Asia Pacific Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


Asia Pacific Generic Injectables Market Segmentation   
The Asia Pacific generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the Asia Pacific generic injectables market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the Asia Pacific generic injectables market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China contributed a substantial share in 2020. 

AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the Asia-Pacific generic injectables market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Generic injectables Market – By Product Type

1.3.2        APAC Generic injectables Market – By Container Type

1.3.3        APAC Generic injectables Market – By Application

1.3.4        APAC Generic injectables Market – By Route of Administration

1.3.5        APAC Generic injectables Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Generic Injectables Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Generic Injectables Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Low R&D, Marketing, and Manufacturing Costs

5.1.2        High Demand for Affordable Drugs

5.2         Market Restraints

5.2.1        Critical Inspection System for Prefilled Injection

5.3         Market Opportunities

5.3.1        Increasing Patent Expiry of Drugs

5.4         Future Trends

5.4.1        Government Support for Generic Injectables Production and Healthcare Cost Reduction

5.5         Impact Analysis

6.           Generic Injectables Market– APAC Analysis

6.1         APAC Generic Injectables Market Revenue Forecast and Analysis

7.           APAC Generic Injectables Market– by Product Type

7.1         Overview

7.2         APAC Generic Injectables Market, By Product Type, 2021 & 2028 (%)

7.3         Large Molecule Injectables

7.3.1        Overview

7.3.2        Large Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

7.4         Small Molecule Injectables

7.4.1        Overview

7.4.2        Small Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.           APAC Generic Injectables Market– by Container Type

8.1         Overview

8.2         APAC Generic Injectables Market, By Container Type, 2021 & 2028 (%)

8.3         Vials

8.3.1        Overview

8.3.2        Vials: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.4         Premix

8.4.1        Overview

8.4.2        Premix: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.5         Prefilled Syringes

8.5.1        Overview

8.5.2        Prefilled Syringes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.6         Ampoules

8.6.1        Overview

8.6.2        Ampoules: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.           APAC Generic Injectables Market– by Application

9.1         Overview

9.2         APAC Generic Injectables Market, By Application, 2021 & 2028 (%)

9.3         Oncology

9.3.1        Overview

9.3.2        Oncology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.4         Infectious Diseases

9.4.1        Overview

9.4.2        Infectious Diseases: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.6         Diabetes

9.6.1        Overview

9.6.2        Diabetes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.7         Immunology

9.7.1        Overview

9.7.2        Immunology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9.8         Others

9.8.1        Overview

9.8.2        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.        APAC Generic Injectables Market– by Route of Administration

10.1      Overview

10.2      APAC Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)

10.3      Intravenous

10.3.1     Overview

10.3.2     Intravenous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.4      Intramuscular

10.4.1     Overview

10.4.2     Intramuscular: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.5      Subcutaneous

10.5.1     Overview

10.5.2     Subcutaneous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10.6      Others

10.6.1     Overview

10.6.2     Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11.        APAC Generic Injectables Market– Country Analysis

11.1      APAC: Generic Injectables Market

11.1.1     Overview

11.1.3     APAC: Generic Injectables Market, by Country, 2021 & 2028 (%)

11.1.3.1       China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.1.1       China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.1.2       China: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.1.3       China: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.1.4       China: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.1.5       China: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.2       Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.2.1       Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.2.2       Japan: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.2.3       Japan: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.2.4       Japan: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.2.5       Japan: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.3       India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.3.1       India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.3.2       India: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.3.3       India: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.3.4       India: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.3.5       India: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.4       Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.4.1       Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.4.2       Australia: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.4.3       Australia: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.4.4       Australia: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.4.5       Australia: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.5       South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.5.1       South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.5.2       South Korea: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.5.3       South Korea: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.5.4       South Korea: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.5.5       South Korea: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

11.1.3.6       Rest of APAC: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.6.1       Rest of APAC: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

11.1.3.6.2       Rest of APAC: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)

11.1.3.6.3       Rest of APAC: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)

11.1.3.6.4       Rest of APAC: Generic Injectables Market, by Application, 2019–2028 (USD Million)

11.1.3.6.5       Rest of APAC: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)

12.        APAC Generic Injectables Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      AstraZeneca

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Baxter International Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Biocon

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Fresenius SE & Co. KGaA

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      GlaxoSmithKline plc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Johnson and Johnson Services, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Lupin

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Viatris Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Merck & Co., Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Pfizer Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             APAC Generic injectables Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             China Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             China Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          India Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          India Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          India Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          India Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Australia Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of APAC Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of APAC Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments Done By Companies

Table 27.          Inorganic Developments Done By Companies

Table 28.          Glossary of Terms, APAC Generic Injectables Market

 


LIST OF FIGURES

Figure 1.           APAC Generic injectables Market Segmentation

Figure 2.           APAC Generic injectables Market, By Country

Figure 3.           APAC Generic Injectables Market Overview

Figure 4.           Large Molecule Injectable Segment Held Largest Share of Product Type Segment in APAC Generic injectables Market

Figure 5.           India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           APAC Generic injectables Market Impact Analysis of Driver and Restraints

Figure 9.           APAC Generic injectables Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        APAC Generic Injectables Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Large Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Small Molecule Injectables: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC Generic Injectables Market, by Container Type, 2021 & 2028 (%)

Figure 14.        Vials: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Premix: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Prefilled Syringes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Ampoules: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        APAC Generic Injectables Market, by Application, 2021 & 2028 (%)

Figure 20.        Oncology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Infectious Diseases: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Cardiology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diabetes: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Immunology: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        APAC Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)

Figure 27.        Intravenous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Intramuscular: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Subcutaneous: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Others: APAC Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        APAC: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)

Figure 32.        China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Rest of APAC: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)

  1. AstraZeneca
  2. Baxter International Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline plc
  6. Johnson and Johnson Services, Inc.
  7. Lupin
  8. Merck & Co., Inc.
  9. Pfizer Inc.
  10. Viatris Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000